Hibino M, Uryu K, Takeda T, Kunimatsu Y, et al. Safety and Immunogenicity of mRNA Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Lung Cancer Receiving Immune Checkpoint Inhibitors: A Multicenter Observational Study in Japan. J Thorac Oncol 2022 Jun 22. pii: S1556-0864(22)00295.
PMID: 35752437